These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 6843560)

  • 21. [New aspects in the treatment of patent ductus arteriosus in premature newborns with respiratory insufficiency].
    Weninger M; Pollak A; Salzer-Muhar U; Simbruner G; Salzer HR; Rosenkranz M
    Z Geburtshilfe Perinatol; 1989; 193(5):226-9. PubMed ID: 2815899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis.
    Heymann MA; Rudolph AM; Silverman NH
    N Engl J Med; 1976 Sep; 295(10):530-3. PubMed ID: 950959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].
    Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL
    Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Management of persistent ductus arteriosus in the newborn with respiratory insufficiency].
    Hurtado del Rio D; Holden Barker AM; Pezzotti MA; Gutiérrez Bosque R; Archundia A; Pérez Mejia J; Carrillo H
    Arch Inst Cardiol Mex; 1979; 49(4):662-72. PubMed ID: 485672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic indomethacin: factors determining permanent ductus arteriosus closure.
    Narayanan M; Cooper B; Weiss H; Clyman RI
    J Pediatr; 2000 Mar; 136(3):330-7. PubMed ID: 10700689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary excretion rates of 6-keto-PGF1 alpha in preterm infants recovering from respiratory distress with and without patent ductus arteriosus.
    Seyberth HW; Müller H; Ulmer HE; Wille L
    Pediatr Res; 1984 Jun; 18(6):520-4. PubMed ID: 6588360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Persistent ductus arteriosus in premature infants].
    Petersen S; Christensen NC; Lauridsen P; Pedersen SA; Ryssing E
    Ugeskr Laeger; 1983 Nov; 145(46):3560-3. PubMed ID: 6649139
    [No Abstract]   [Full Text] [Related]  

  • 28. Nonsurgical closure of patent ductus arteriosus in preterm infants.
    Smith ME
    Heart Lung; 1979; 8(2):308-10. PubMed ID: 253708
    [No Abstract]   [Full Text] [Related]  

  • 29. The relationship of symptomatic patent ductus arteriosus to respiratory distress in premature newborn infants.
    Cotton RB
    Clin Perinatol; 1987 Sep; 14(3):621-33. PubMed ID: 3311542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacologic treatment of patent ductus arteriosus in premature infants].
    Vázquez C; Cabrera A; Pastor E; Valls y Soler A
    An Esp Pediatr; 1983 Jun; 18(6):482-8. PubMed ID: 6625369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
    Quinn D; Cooper B; Clyman RI
    Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for persistent ductus arteriosus patency during indomethacin treatment.
    Chorne N; Jegatheesan P; Lin E; Shi R; Clyman RI
    J Pediatr; 2007 Dec; 151(6):629-34. PubMed ID: 18035143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and clinical efficacy of indomethacin in premature infants with patent ductus arteriosus.
    Regazzi MB; Rondanelli R; Vidale E; Chirico G; Rondini G; Chiara A; Piccolo A
    Int J Clin Pharmacol Res; 1984; 4(2):109-12. PubMed ID: 6469435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Indomethacin or ligation in the treatment of persistent ductus arteriosus: a report of clinical experiences].
    Sterniste W; Fürnkranz H
    Padiatr Padol; 1989; 24(2):153-9. PubMed ID: 2762001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Indomethacin in IRDS with PDA phenomenon (author's transl)].
    Müller WD; Zach M; Stix H; Rosegger H; Beitzke A
    Klin Padiatr; 1979 Sep; 191(5):460-6. PubMed ID: 574578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Indomethacin and furosemide in closure of ductus arteriosus].
    Vargas-Origel A; Cruz-Anguiano V; López-Montaño E
    Bol Med Hosp Infant Mex; 1986 Aug; 43(8):482-8. PubMed ID: 3755939
    [No Abstract]   [Full Text] [Related]  

  • 38. [Controlled trial of intravenous lyophilized indomethacin in the treatment of persistent ductus arteriosus in premature infants].
    Monset-Couchard M; Dias-Mançano D; Murat I; Relier JP
    Pediatrie; 1983 Sep; 38(6):365-77. PubMed ID: 6364030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The patent ductus arteriosus.
    Friedman WF; Fitzpatrick KM; Merritt TA; Feldman BH
    Clin Perinatol; 1978 Sep; 5(2):411-36. PubMed ID: 371899
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.